| We continue to expect the drug to gain momentum and ramp sharply as the year progresses, with inclusion of the BOSTON data on the label | FDA The company received the expanded approval earlier than the March anticipated PDUFA date |
|---|---|
| Probably because Richard Paulson rightly decided he can't throw money at everything under the sun like his predecessor who didn't seem to have a sense of what constitutes shareholder value, and you can't rely on shareholders indefinitely as ATM machines and burn through cash like wildfire | Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them |
| Shares short fall in May from the previous month at 14 | I assume institutions have a similar sentiment |
|---|---|
| I'm not impressed with their management of Karyopharm but scientifically they're geniuses | It lists the partner's share of income, deductions, credits, etc |
He puts Cindy McGee, Craig Audet, Russo and the rest of amateurish IR team in his back pocket.
| Could have dropped these bags multiple times and been fine with other plays but I held | News, commentary and events are from third-party sources unaffiliated with Fidelity |
|---|---|
| Not sure if his version is relapsed or refractory though | One set of page table for use in kernel mode includes both kernel-space and user-space |
Be patient and be an investor not a trader with this one.
28